A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.

Clinical trial NCT00472420 · COMPLETED

Trial details

NCT number: NCT00472420
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2007-06-27
Primary completion: 2011-05-25
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.